Using functional magnetic resonance imaging, we measured amygdala reactivity to faces varying on threat intensity in patients with generalized social phobia (GSP) and healthy controls. GSP patients exhibited greater amygdala reactivity to threat faces at high and moderate intensities. More subtle displays of social threat are sufficient to evoke a fear-related neural response.
Introduction
Generalized social phobia (GSP) is characterized by excessive fear and avoidance of public scrutiny, particularly in the context of social evaluative threat (Stein and Stein, 2008) . These fears often manifest when confronted by facial expressions that convey potent emotional information (Ekman, 2003) . A growing number of studies have consistently demonstrated that patients with GSP exhibit exaggerated amygdala reactivity to "harsh" (angry, fearful, and/or disgusted) faces (for review, see Etkin and Wager, 2007; Evans et al., 2008) .
The amygdala is particularly sensitive to threatening social signals (Zald, 2003) , and is critically involved in the perception of potential of danger (Amaral, 2003) . More intense facial displays of threat appear to engage greater amygdala activity (Winston et al., 2003) . Given that "harsh" faces convey the most salient information to patients with GSP, they may have a lower threshold of amygdala activation to perceived threat. In support of this notion, behavioral studies have shown that GSP subjects more accurately identify the presence of threat even at moderate intensity (Joormann and Gotlib, 2006) . However, no study has examined amygdala reactivity to faces that convey threat at varying levels of intensity.
In this functional magnetic resonance imaging (fMRI) study, we measured amygdala reactivity to threatening faces of low, moderate, and high intensity. We hypothesized that GSP, relative to controls, would exhibit greater amygdala reactivity to "harsh" faces of both high and moderate intensity.
Methods

Subjects
Twelve individuals with GSP (age: 28.2 ± 8.6 years), as confirmed by the Structured Clinical Interview for DSM-IV (First et al., 1995) with additional probes from the Liebowitz Social Anxiety Scale (Liebowitz, 1987) , and 12 healthy control (HC) subjects (age: 33.6 ± 9.6 years) participated. None of the GSP patients had a current depressive episode or recent substance abuse/dependence (within 6 months of study), or a lifetime history of major psychiatric illness (e.g., bipolar, psychotic disorder). Although two of the patients had co-morbid generalized anxiety disorder, social phobia was their primary diagnosis. All subjects were right-handed and free of current/ past major medical or neurologic illness, as confirmed by a physician. All subjects were free of psychoactive medications at the time of the study and none tested positive for alcohol or illegal substances. GSP and HC groups were similar in age, education level, gender and race/ ethnicity (t-tests/χ 2 tests, all P s N 0.05). All subjects provided written informed consent, as approved by the local Institutional Review Board.
Behavioral task and functional MRI
In a jittered, event-related fMRI design, subjects viewed a stimulus set consisting of black/white photographs of standardized faces (Ekman and Friesen, 1976 ) morphed (using techniques described by Young et al. (1997) ) at low (20-30%), moderate (50-60%), and high 
